H&F Is Said to Explore Sale of Cordis for Up to $10 Billion (1)

Hellman & Friedman is exploring a potential sale of medical device company Cordis, people familiar with the matter said.

The private equity firm is working with advisers to field interest in Cordis, which makes stents and other products used in cardiovascular procedures, according to the people. H&F is seeking a value of more than $9 billion to as much as $10 billion for Cordis, they said.

About half a dozen publicly traded medical device companies are evaluating potential bids, the people said, asking not to be identified because the information is confidential.

Deliberations are at an early stage and ...